Log in
Enquire now

List of Regulus Therapeutics patents

List of Regulus Therapeutics patents
List of JBS USA patents
List of Excellims Corporation patents
List of Orthobond Corporation patents
List of nanosatellite products
List of funding rounds for VMware
Patents where
Current Assignee
Name
is
Regulus TherapeuticsRegulus Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9359609 Methods for treatment of alport syndrome

Patent 9359609 was granted and assigned to Regulus Therapeutics on June, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9359609
June 7, 2016
‌
US Patent 9309513 MicroRNA compounds and methods for modulating miR-122

Patent 9309513 was granted and assigned to Regulus Therapeutics on April, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9309513
April 12, 2016
‌
US Patent 10150967 MicroRNA compounds and methods for modulating miR-122

Patent 10150967 was granted and assigned to Regulus Therapeutics on December, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10150967
December 11, 2018
‌
US Patent 9574194 MicroRNA compounds and methods for modulating miR-122

Patent 9574194 was granted and assigned to Regulus Therapeutics on February, 2017 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9574194
February 21, 2017
‌
US Patent 9157083 MicroRNA compounds and methods for modulating miR-122

Patent 9157083 was granted and assigned to Regulus Therapeutics on October, 2015 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9157083
October 13, 2015
‌
US Patent 9688985 MicroRNA compounds and methods for modulating miR-21 activity

Patent 9688985 was granted and assigned to Regulus Therapeutics on June, 2017 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9688985
June 27, 2017
‌
US Patent 9970009 MicroRNA compounds and methods for modulating miR-21 activity

Patent 9970009 was granted and assigned to Regulus Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9970009
May 15, 2018
‌
US Patent 9506030 Compounds and methods for enhanced cellular uptake

Patent 9506030 was granted and assigned to Regulus Therapeutics on November, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9506030
November 29, 2016
‌
US Patent 10941400 Compounds and methods for enhanced cellular uptake

Patent 10941400 was granted and assigned to Regulus Therapeutics on March, 2021 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10941400
March 9, 2021
‌
US Patent 10240151 Compounds and methods for enhanced cellular uptake

Patent 10240151 was granted and assigned to Regulus Therapeutics on March, 2019 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10240151
March 26, 2019
‌
US Patent 9447412 Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

Patent 9447412 was granted and assigned to Regulus Therapeutics on September, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9447412
September 20, 2016
‌
US Patent 9487783 Targeting microRNAs for metabolic disorders

Patent 9487783 was granted and assigned to Regulus Therapeutics on November, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9487783
November 8, 2016
‌
US Patent 9862950 Targeting microRNAs for metabolic disorders

Patent 9862950 was granted and assigned to Regulus Therapeutics on January, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9862950
January 9, 2018
‌
US Patent 10138484 Targeting microRNAs for metabolic disorders

Patent 10138484 was granted and assigned to Regulus Therapeutics on November, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10138484
November 27, 2018
‌
US Patent 9663787 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 9663787 was granted and assigned to Regulus Therapeutics on May, 2017 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9663787
May 30, 2017
‌
US Patent 9267138 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 9267138 was granted and assigned to Regulus Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9267138
February 23, 2016
‌
US Patent 9528108 Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

Patent 9528108 was granted and assigned to Regulus Therapeutics on December, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9528108
December 27, 2016
‌
US Patent 8178506 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 8178506 was granted and assigned to Regulus Therapeutics on May, 2012 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8178506
May 15, 2012
‌
US Patent 8969317 MicroRNA compounds and methods for modulating miR-21 activity

Patent 8969317 was granted and assigned to Regulus Therapeutics on March, 2015 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8969317
March 3, 2015
‌
US Patent 9267137 MicroRNA compounds and methods for modulating miR-21 activity

Patent 9267137 was granted and assigned to Regulus Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9267137
February 23, 2016
‌
US Patent 10072265 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 10072265 was granted and assigned to Regulus Therapeutics on September, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10072265
September 11, 2018
‌
US Patent 7998677 MicroRNA detection

Patent 7998677 was granted and assigned to Regulus Therapeutics on August, 2011 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7998677
August 16, 2011
‌
US Patent 9994842 Methods for use in modulating miR-122A

Patent 9994842 was granted and assigned to Regulus Therapeutics on June, 2018 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9994842
June 12, 2018
‌
US Patent 8859521 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 8859521 was granted and assigned to Regulus Therapeutics on October, 2014 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8859521
October 14, 2014
‌
US Patent 9139832 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Patent 9139832 was granted and assigned to Regulus Therapeutics on September, 2015 by the United States Patent and Trademark Office.

Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9139832
September 22, 2015
Results per page:
47 results
0 selected
47 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us